Results 201 to 210 of about 137,565 (249)

Bacteriology of complicated parapneumonic effusions

Current Opinion in Pulmonary Medicine, 2007
The bacteriology of complicated parapneumonic effusions has changed in recent decades, but the causative organisms often remain obscure in up to 40% of cases. Recently, new molecular methods have become available which might help clinical management and improve our understanding of this condition.
Sarah, Foster, Nick, Maskell
openaire   +2 more sources

Pleural Fluid Amino Acids Contribute to Distinguishing Tuberculosis, Malignant, and Parapneumonic Pleural Effusion Patients.

Clinical Laboratory
BACKGROUND Differential diagnosis of pleural effusions poses a considerable challenge in clinical practice. In this study, we explored biomarkers in pleural fluid for distinguishing tuberculosis, malignant, and parapneumonic pleural effusion patients ...
Jiangqing Yu, T. Feng, Sheng-Sheng Liu, Tongshun Xie, Tianchen Shi   +4 more
semanticscholar   +1 more source

Epidemiology of pediatric parapneumonic pleural effusion during 13-valent pneumococcal conjugate vaccine implementation.

Enfermedades Infecciosas y Microbiologia Clinica, 2022
INTRODUCTION The reported incidence of parapneumonic pleural effusion, including empyema, has shown fluctuations in the last decades. It has been related to the implementation of different types of conjugate pneumococcal vaccines.
L. Moral, T. Toral, N. Marco, A. Clavijo, F. Canals, M. Forniés, M. C. González, J. Moral, M. Márquez, R. Lucas, M. Caballero, Ana María Huertas, Belén García-Avilés, M. Belda   +13 more
semanticscholar   +1 more source

Parapneumonic Pleural Effusion and Empyema

Respiration, 2008
At least 40% of all patients with pneumonia will have an associated pleural effusion, although a minority will require an intervention for a complicated parapneumonic effusion or empyema. All patients require medical management with antibiotics. Empyema and large or loculated effusions need to be formally drained, as well as parapneumonic effusions ...
Coenraad F N, Koegelenberg, Andreas H, Diacon, Chris T, Bolliger   +2 more
openaire   +2 more sources

Efficiency of Lymphocyte-to-Monocyte Ratio in Differential Diagnosis of Parapneumonic Effusion and Thoracic Empyema

Surgical Infections, 2020
Background: Parapneumonic effusion (PPE) and thoracic empyema (TE) necessitate prompt differential diagnosis regarding their unequal rates of mortality and disparate methods of treatment.
M. Sarıçam
semanticscholar   +1 more source

Parapneumonic Effusions and Empyema

Clinics in Chest Medicine, 1985
Parapneumonic effusions occur in 20 to 40% of patients who are hospitalized with pneumonia. The mortality rate in patients with a parapneumonic effusion is higher than that in patients with pneumonia without a parapneumonic effusion. Some of the excess mortality is due to mismanagement of the parapneumonic effusion.
openaire   +3 more sources

Next-generation sequencing-based clinical metagenomics identifies Prevotella pleuritidis in a diabetic adolescent with large parapneumonic effusion and negative growth of pleural fluid culture: a case report

British Journal of Biomedical Science, 2020
We report a 12-year-old diabetic boy with a right-sided parapneumonic effusion and pneumonia who failed initial empirical antibiotics. Prevotella pleuritidis was identified from the pleural fluid using next-generation sequencing-based clinical ...
T. Galliguez, P. Tsou, A. Cabrera, J. Fergie   +3 more
semanticscholar   +1 more source

Metabolomic profiling of parapneumonic effusion reveals a regulatory role of dipeptides in interleukin-8 production in neutrophil-like cells.

Analytica Chimica Acta, 2020
Bacterial pneumonia is a lethal condition, and approximately 40% of bacterial pneumonia patients experience parapneumonic effusion (PPE). Based on the severity of inflammation, PPEs can be categorized as early-stage uncomplicated PPE (UPPE), advanced ...
P. Hsueh, Kuo-An Wu, Chia-Yu Yang, Chia-Wei Hsu, Chih-Liang Wang, Chu-Mi Hung, Yi-Ting Chen, Jau-Song Yu, Chih-Ching Wu   +8 more
semanticscholar   +1 more source

Management of parapneumonic pleural effusion in children: Is there a role for corticosteroids when conventional nonsurgical management fails? A single‐center 15‐year experience

Pediatric Pulmonology, 2021
Description of the use of corticosteroids for the management of parapneumonic pleural effusion in children.
Matthieu Thimmesch, A. Mulder, F. Lebrun, F. Piérart, C. Genin, I. Loeckx, P. Demaret   +6 more
semanticscholar   +1 more source

Alteplase: Pleural Effusion (Parapneumonic)

Hospital Pharmacy, 2003
Off-Label Drug Uses This Hospital Pharmacy feature is extracted from Off-Label DrugFacts, a quarterly publication available from Facts and Comparisons. Off-Label DrugFacts is a practitioner-oriented resource for information about specific FDA-unapproved drug uses.
Joyce Generali, Dennis J. Cada
openaire   +1 more source